Composition:
Palbociclib 75mg / 100mg / 125mg
Description:
Piclib is an advanced oncology therapy designed to slow the progression of HR-positive, HER2-negative metastatic breast cancer. It contains palbociclib, a CDK4/6 inhibitor that targets proteins responsible for cell division, effectively halting the proliferation of cancer cells. Used in combination with hormonal therapies, Piclib helps extend progression-free survival and provides a targeted treatment approach with manageable side effects.
It has become a critical component in breast cancer care, especially for patients seeking a well-tolerated oral option that works at the cellular level to delay disease advancement.
Share your experience with our medical product. Write a review!
01 Jun 2026
Salt, Stress, and Sedentary Life: The Three Big Triggers of Hypertension
Every two seconds, somewhere in the world, a person suffers a heart attack or stroke linked to uncontrolled blood pressure.
25 Apr 2026
World Liver Day 2026: Signs, Causes & How to Protect Your Liver Naturally
The liver is one of the most vital organs in the human body, responsible for detoxification, metabolism, and nutrient storage. Yet, liver health is often overlooked until symptoms become serious.
15 Apr 2026
World Health Day 2026: Small Health Habits That Prevent Big Diseases
Every year, World Health Day reminds us of something very simple yet powerful-our health deserves attention every single day, not only when something goes wrong. World Health Day 2026 is a good moment
25 Mar 2026
Transdermal Patches 2026: Latest Trends, Benefits & How They’re Revolutionizing Pain & Nicotine Relief
Transdermal patches are advanced drug delivery systems that deliver medication through the skin directly into the bloodstream. In 2026, new health technology trends are making transdermal patches more